Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA.
Kadlec Regional Medical Center, Richland, WA, USA.
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241233205. doi: 10.1177/21501319241233205.
To assess the prevalence of sleep disturbance among patients evaluated at a clinic for patients afflicted with Post-acute sequelae of COVID-19 (PASC).
Sleep disturbance was assessed with the Patient-Reported Outcomes Measurement Information System-Sleep Disturbance (PROMIS-SD) framework among adult patients of the PASC clinic.
Among 312 patients, the mean age was 46.2 years, and 70.2% were women. About 41.0% of patients had no sleep disturbance; sleep disturbance was mild to moderate in 51.3% and severe in 7.7%. PROMIS-SD score was negatively correlated with the time from the initial positive COVID-19 test to the initial consultation in the PASC clinic (Pearson = -.094; = .0088).
The PROMIS-Sleep Disturbance framework can serve as a tool to assess the burden of sleep disturbances in PASC patients.
评估在新冠病毒疾病（COVID-19）后急性后遗症（PASC）患者诊所就诊的患者中睡眠障碍的患病率。
在 PASC 诊所，使用患者报告结局测量信息系统睡眠障碍（PROMIS-SD）框架评估睡眠障碍。
在 312 名患者中，平均年龄为 46.2 岁，70.2%为女性。约 41.0%的患者没有睡眠障碍；51.3%的患者有轻度至中度睡眠障碍，7.7%的患者有严重睡眠障碍。PROMIS-SD 评分与从最初 COVID-19 检测阳性到 PASC 诊所首次就诊的时间呈负相关（皮尔逊相关系数=-.094；p=0.0088）。
PROMIS-Sleep 障碍框架可用作评估 PASC 患者睡眠障碍负担的工具。
Zotero 插件